Get the Stockscreener App
6.16
7.50%
0.43
Corvus Pharmaceuticals Inc stock is traded at $6.16, with a volume of 1.12M.
It is up +7.50% in the last 24 hours and up +43.59% over the past month.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).
See More
Previous Close:
$5.73
Open:
$5.75
24h Volume:
1.12M
Relative Volume:
1.53
Market Cap:
$459.01M
Revenue:
-
Net Income/Loss:
$-27.03M
P/E Ratio:
-11.00
EPS:
-0.56
Net Cash Flow:
$-23.97M
1W Performance:
+7.32%
1M Performance:
+43.59%
6M Performance:
+49.15%
1Y Performance:
+54.00%
1-Day Range:
$5.74
$6.17
1-Week Range:
$5.58
$6.17
52-Week Range:
$2.54
$10.00
Corvus Pharmaceuticals Inc Stock (CRVS) Company Profile
Name
Corvus Pharmaceuticals Inc
Sector
Industry
Phone
(650) 900-4520
Address
863 MITTEN ROAD, BURLINGAME, CA
Compare CRVS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CRVS
Corvus Pharmaceuticals Inc
|
6.16 | 426.97M | 0 | -27.03M | -23.97M | -0.56 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Corvus Pharmaceuticals Inc Stock (CRVS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-02-25 | Initiated | H.C. Wainwright | Buy |
| Aug-18-23 | Initiated | Oppenheimer | Outperform |
| Dec-01-21 | Resumed | Jefferies | Buy |
| May-27-21 | Initiated | Cantor Fitzgerald | Overweight |
| Feb-10-21 | Downgrade | Mizuho | Buy → Neutral |
| Sep-12-19 | Initiated | Mizuho | Buy |
| May-29-19 | Initiated | ROTH Capital | Buy |
| Aug-24-17 | Upgrade | Credit Suisse | Underperform → Neutral |
| May-01-17 | Downgrade | Credit Suisse | Neutral → Underperform |
| Apr-18-16 | Initiated | Credit Suisse | Outperform |
| Apr-18-16 | Initiated | Guggenheim | Buy |
View All
Corvus Pharmaceuticals Inc Stock (CRVS) Latest News
Pattern recognition hints at Corvus Pharmaceuticals Inc. upside2025 Retail Activity & Stepwise Trade Signal Implementation - Newser
Analyzing Corvus Pharmaceuticals Inc. with multi timeframe chartsTrade Risk Assessment & Long Hold Capital Preservation Plans - Newser
Is Corvus Pharmaceuticals Inc. stock poised for growth2025 Top Decliners & Safe Swing Trade Setups - Newser
Will earnings trigger a reversal in Corvus Pharmaceuticals Inc.Quarterly Profit Review & High Accuracy Buy Signal Tips - Newser
Visual trend scoring systems applied to Corvus Pharmaceuticals Inc.2025 Investor Takeaways & Daily Technical Stock Forecast Reports - Newser
Exit strategy if you’re trapped in Corvus Pharmaceuticals Inc.Weekly Profit Analysis & Consistent Return Investment Signals - Newser
Strategies to average down on Corvus Pharmaceuticals Inc.July 2025 Sector Moves & Weekly Market Pulse Updates - Newser
regression analysis insights on corvus pharmaceuticals inc. performanceShare Buyback & Verified Momentum Stock Watchlist - Newser
Using R and stats models for Corvus Pharmaceuticals Inc. forecasting2025 Market Sentiment & Fast Moving Trade Plans - Newser
Will Corvus Pharmaceuticals Inc. announce a stock split2025 Market Trends & Free Expert Verified Stock Movement Alerts - خودرو بانک
Is Corvus Pharmaceuticals Inc. stock ready for a breakoutMarket Performance Report & Long-Term Capital Growth Ideas - Newser
Does Corvus Pharmaceuticals Inc. outperform in volatile marketsBreakout Watch & Community Consensus Trade Alerts - خودرو بانک
Comparing Corvus Pharmaceuticals Inc. in custom built stock radarsJuly 2025 Spike Watch & Daily Chart Pattern Signal Reports - Newser
Using Ichimoku Cloud for Corvus Pharmaceuticals Inc. technicalsWeekly Profit Summary & Fast Gain Stock Tips - Newser
Can momentum traders help lift Corvus Pharmaceuticals Inc.Volume Spike & Comprehensive Market Scan Insights - Newser
Does Corvus Pharmaceuticals Inc. meet Warren Buffett’s criteriaMarket Volume Summary & Short-Term Trading Alerts - خودرو بانک
Statistical indicators supporting Corvus Pharmaceuticals Inc.’s strengthJuly 2025 Opening Moves & Weekly High Return Stock Forecasts - Newser
Will Corvus Pharmaceuticals Inc. stock go up in YEARMarket Volume Summary & Advanced Swing Trade Entry Plans - خودرو بانک
Reversal indicators forming on Corvus Pharmaceuticals Inc. stockJuly 2025 Recap & Low Risk Growth Stock Ideas - Newser
Can you recover from losses in Corvus Pharmaceuticals Inc.2025 Valuation Update & AI Based Buy and Sell Signals - Newser
Price momentum metrics for Corvus Pharmaceuticals Inc. explainedTrade Entry Summary & Proven Capital Preservation Methods - Newser
What MACD signals say about Corvus Pharmaceuticals Inc.2025 Market Trends & Weekly Watchlist for Hot Stocks - Newser
Sentiment analysis tools applied to Corvus Pharmaceuticals Inc.July 2025 EndofMonth & Safe Capital Growth Tips - Newser
Analyzing recovery setups for Corvus Pharmaceuticals Inc. investorsWeekly Trade Analysis & Reliable Intraday Trade Alerts - Newser
How to monitor Corvus Pharmaceuticals Inc. with trend dashboardsEntry Point & Smart Investment Allocation Insights - Newser
Is Corvus Pharmaceuticals Inc. stock undervalued right nowJuly 2025 Closing Moves & Weekly High Return Stock Opportunities - خودرو بانک
Merger Talk: Will Corvus Pharmaceuticals Inc. stock hit new highs in YEAR2025 Dividend Review & Low Volatility Stock Suggestions - خودرو بانک
What is Corvus Pharmaceuticals Inc.’s TAM (Total Addressable Market)2025 Winners & Losers & Risk Adjusted Swing Trade Ideas - خودرو بانک
Analyzing drawdowns of Corvus Pharmaceuticals Inc. with statistical toolsJuly 2025 Macro Moves & Community Verified Swing Trade Signals - Newser
Will Corvus Pharmaceuticals Inc. price bounce be sustainableMarket Performance Report & Verified Short-Term Plans - Newser
Short interest data insights for Corvus Pharmaceuticals Inc.Weekly Trade Recap & Verified Momentum Watchlists - Newser
Forecasting Corvus Pharmaceuticals Inc. price range with options dataTake Profit & Expert Curated Trade Setup Alerts - Newser
Corvus Pharmaceuticals Inc. stock trend forecastNew Guidance & AI Driven Stock Movement Reports - Newser
Published on: 2025-09-03 09:32:09 - Newser
Will Corvus Pharmaceuticals Inc. outperform its industry peersJuly 2025 Gainers & Reliable Price Action Trade Plans - خودرو بانک
Understanding Corvus Pharmaceuticals Inc.’s price movementWeekly Market Report & Technical Pattern Based Signals - Newser
Why is Corvus Pharmaceuticals Inc. stock going downJuly 2025 Snapshot & Weekly High Return Opportunities - خودرو بانک
Corvus Pharmaceuticals Inc. stock daily chart insightsJuly 2025 Trade Ideas & AI Enhanced Execution Alerts - Newser
AI Indicators Detect Buy Opportunity in Corvus Pharmaceuticals Inc. getLinesFromResByArray error: size == 0 - 강소기업뉴스
Corvus Pharmaceuticals Inc Stock (CRVS) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):